Suma Krishnan - Precigen Senior Vice President - Product Development
President
Mrs. Suma M. Krishnan is Senior Vice President, Product Development Head of Human Therapeutics Divisiono of Intrexon Corporationrationration. since 2014. prior to that was Senior Vice President, Regulatory Affairs since 2012. From 2009 to 2011, Mrs. Krishnan served as Senior Vice President of Product Development at Pinnacle Pharmaceuticals, Inc. From 2007 to 2009, she served as Chief Financial Officer of Light Matters Foundation. Previously, Mrs. Krishnan was Vice President, Product Development at New River Pharmaceuticals Inc. from September 2002 until its acquisition by Shire plc in April 2007. Mrs. Krishnan has 22 years experience in drug development. Prior to serving at New River Pharmaceuticals Inc., Mrs. Krishnan served in the following capacities Director, Regulatory Affairs at Shire Pharmaceuticals, Inc., a specialty pharmaceutical company Senior Project Manager at Pfizer, Inc., a multinational pharmaceutical company and a consultant at the Weinberg Group, a pharmaceutical and environmental consulting firm. Mrs. Krishnan began her career as a discovery scientist for Janssen Pharmaceuticals, Inc., a subsidiary of Johnson Johnson, a multinational pharmaceutical company, in May 1991. Mrs. Krishnan received an M.S. in Organic Chemistry from Villanova University, an M.B.A. from Institute of Management and Research and an undergraduate degree in Organic Chemistry from Ferguson University . since 2016.
Age | 49 |
Tenure | 8 years |
Professional Marks | MBA |
Phone | 301 556-9900 |
Web | www.dna.com |
Suma Krishnan Latest Insider Activity
Tracking and analyzing the buying and selling activities of Suma Krishnan against Precigen stock is an integral part of due diligence when investing in Precigen. Suma Krishnan insider activity provides valuable insight into whether Precigen is net buyers or sellers over its current business cycle. Note, Precigen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Precigen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Suma Krishnan over two weeks ago Disposition of 800 shares by Suma Krishnan of Krystal Biotech at 174.1313 subject to Rule 16b-3 | ||
Suma Krishnan over three months ago Sale by Suma Krishnan of 2854 shares of Krystal Biotech | ||
Suma Krishnan over six months ago Sale by Suma Krishnan of 5007 shares of Krystal Biotech | ||
Suma Krishnan over six months ago Sale by Suma Krishnan of 20143 shares of Krystal Biotech |
Precigen Management Efficiency
Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities.The company has 260.44 M in debt with debt to equity (D/E) ratio of 114.0, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Precigen has a current ratio of 1.88, which is typical for the industry and considered as normal. Debt can assist Precigen until it has trouble settling it off, either with new capital or with free cash flow. So, Precigen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Precigen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Precigen to invest in growth at high rates of return. When we think about Precigen's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | PRESIDENT Age | ||
Isaac Kalish | One Liberty Properties | 49 | |
Jeffrey Klauder | SEI Investments | 64 | |
Lawrence Ricketts | One Liberty Properties | 47 | |
James Hughes | MGIC Investment Corp | 61 | |
Paul Klauder | SEI Investments | 50 | |
Benjamin Bolanos | One Liberty Properties | 27 | |
Salvatore Miosi | MGIC Investment Corp | 56 | |
Stephen Mackey | MGIC Investment Corp | 57 | |
Michael Peterson | SEI Investments | 56 | |
Scott Melbye | Uranium Energy Corp | 62 | |
Ryan Hicke | SEI Investments | 45 | |
Robert Candelmo | MGIC Investment Corp | 60 | |
Michal Tsur | Kaltura | 50 | |
Richard Figueroa | One Liberty Properties | 56 | |
Paula Maggio | MGIC Investment Corp | 55 | |
Robert Crudup | SEI Investments | 69 | |
Evan Elstein | Evolution Mining | N/A | |
Israel Rosenzweig | One Liberty Properties | 77 | |
Glenton Masterman | Evolution Mining | N/A | |
Nathaniel Colson | MGIC Investment Corp | 40 | |
Gregory Chi | MGIC Investment Corp | 57 |
Management Performance
Return On Equity | -1.52 | |||
Return On Asset | -0.0059 |
Precigen Leadership Team
Elected by the shareholders, the Precigen's board of directors comprises two types of representatives: Precigen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Precigen. The board's role is to monitor Precigen's management team and ensure that shareholders' interests are well served. Precigen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Precigen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steven Frank, Independent Director | ||
Robert Walsh, Senior Vice President - Energy and Chemicals Sector | ||
Thomas Kasser, Senior Vice President - Food Sector | ||
Corey Huck, senior Vice President Food Sector | ||
Gregory Frost, Sr. VP of Health Sector | ||
Randal Kirk, Chairman of the Board, CEO | ||
Andrew Last, COO | ||
Christopher Basta, Vice President - Investor Relations | ||
Rick Sterling, CFO | ||
Krish Krishnan, COO | ||
Cesar Alvarez, Independent Director | ||
Donald Lehr, Chief Legal Officer | ||
Joseph Vaillancourt, Senior Vice President Environment Sector | ||
Jeffrey Perez, Senior Vice President — Intellectual Property Affairs | ||
Joel Liffmann, Senior Vice President - Finance | ||
Helen Sabzevari, President of Precigen, Inc. | ||
Dean Mitchell, Independent Director | ||
Robert Shapiro, Independent Director | ||
Geno Germano, President | ||
Jeffrey Kindler, Independent Director | ||
Jack Bobo, Senior Vice President Chief Communications Officer | ||
Ena Cratsenburg, Senior Vice President - Consumer Sector | ||
Thomas Bostick, COO | ||
Samuel Broder, Executive Vice President - Scientific and Public Affairs | ||
Suma Krishnan, Senior Vice President - Product Development | ||
Vinita Gupta, Director | ||
Fred Hassan, Director | ||
James Turley, Independent Director | ||
Darryl Webster, Senior Vice President - Intellectual Property | ||
Nir Nimrodi, Sr. VP of Corporate Devel. and Environment Sector | ||
Thomas Reed, Founder and Chief Science Officer |
Precigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Precigen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.52 | |||
Return On Asset | -0.0059 | |||
Profit Margin | (62.86) % | |||
Operating Margin | (326.37) % | |||
Current Valuation | 849.06 M | |||
Shares Outstanding | 168.66 M | |||
Shares Owned By Insiders | 16.01 % | |||
Shares Owned By Institutions | 75.15 % | |||
Number Of Shares Shorted | 33.33 M | |||
Price To Earning | (16.30) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Precigen Stock
If you are still planning to invest in Precigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Precigen's history and understand the potential risks before investing.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |